Cabiralizumab (Anti-CSF1R / M-CSFR / CD115)

Synonyms: FPA 008

Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) is an monoclonal antibody (MAb) targeting CSF1R. It can be used in the research of rheumatoid arthritis (RA), melanoma, kidney cancer, or non-small cell lung cancer. MW :146.3 KD.

Cabiralizumab (Anti-CSF1R / M-CSFR / CD115)

Purity & Quality Control

Batch: A264401 Purity: 99% Protein concentration: 5.74mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective CSF-1R Inhibitors

Biological Activity

Description Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) is an monoclonal antibody (MAb) targeting CSF1R. It can be used in the research of rheumatoid arthritis (RA), melanoma, kidney cancer, or non-small cell lung cancer. MW :146.3 KD.

Product Details

CAS No. 1613144-80-1
Molecular Weight 146.3
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) | Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) supplier | purchase Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) | Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) cost | Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) manufacturer | order Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) | Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) distributor